Skip to main content
. 2013 May 28;2(8):e25123. doi: 10.4161/onci.25123

graphic file with name onci-2-e25123-g1.jpg

Figure 1. Effects of immunomodulatory oligonucleotides and everolimus on neoplastic lesions. Mechanisms of action of immunomodulatory oligonucleotides (IMOs) and the mTOR inhibitor everolimus on different cell populations of the tumor microenvironment, including malignant, endothelial as well as immune cells.